Forte Biosciences Ratios (2016-2020) | FBRX

Ratios Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020
Profitability
EBT Margin 1,637.63%1,640.04%1,797.80%1,620.88%1,509.42%-82,218.18%-99,530.00%-108,370.00%-143,111.11%-178,766.67%6.25%-215,711.11%-189,822.22%-190,155.56%-208,166.67%-117,588.89%1,242.72%
EBIT Margin 1,547.24%1,548.78%1,706.20%1,527.39%1,413.72%-78,654.55%-97,370.00%-106,870.00%-142,733.33%-170,300.00%7.92%-212,311.11%-187,455.56%-186,833.33%-190,255.56%-118,911.11%1,150.40%
EBITDA Margin 1,626.18%1,631.91%1,800.00%1,616.67%1,499.83%-82,472.73%-99,490.00%-108,680.00%-143,933.33%-178,166.67%-1.95%-217,811.11%-189,366.67%-189,733.33%-208,311.11%-117,955.56%1,361.11%
Operating Margin 1,547.24%1,548.78%1,706.20%1,527.39%1,413.72%-78,654.55%-97,370.00%-106,870.00%-142,733.33%-170,300.00%7.92%-212,311.11%-187,455.56%-186,833.33%-190,255.56%-118,911.11%1,150.40%
Net Margin 1,637.63%1,640.04%1,797.80%1,620.88%1,509.42%-82,218.18%-99,530.00%-108,370.00%-143,111.11%-178,766.67%-2.13%-217,811.11%-189,822.22%-190,155.56%-208,166.67%-117,588.89%1,242.72%
FCF Margin 1,262.99%1,632.32%1,619.80%1,486.21%1,259.50%-67,800.00%-72,200.00%-94,900.00%-143,644.44%-126,888.89%1.81%-137,944.44%-197,944.44%177,700.00%-4,100.00%-8,244.44%378.97%
Efficiency
Assets Average 34.82M72.53M106.47M97.12M85.41M83.04M88.84M96.72M98.90M89.98M77.99M39.20M13.14M23.47M25.52M
Equity Average -128.67M-22.18M84.34M75.60M65.38M52.88M46.88M52.91M51.50M40.67M28.14M7.52M-1.34M13.48M22.60M
Invested Capital -124.42M-132.92M88.57M80.11M71.08M59.68M46.09M47.67M58.15M44.85M36.49M19.80M-4.77M2.08M24.88M20.32M
Asset Utilization Ratio -0.06-0.02-0.01-0.010.000.000.200.190.180.200.000.00-0.06
Leverage & Solvency
Interest Coverage Ratio -15.04-15.09-16.69-14.96-13.88-17.48-22.64-27.33-36.81-14.021.92-25.61-22.38-22.01-8.68-32.43-11.50
Debt to Equity -0.08-0.060.080.070.050.030.560.550.450.540.61
Debt Ratio 0.290.250.060.050.040.030.300.290.250.250.26
Equity Ratio -3.52-3.880.800.780.770.760.530.530.560.470.430.28-0.620.110.880.89
Times Interest Earned -15.04-15.09-16.69-14.96-13.88-17.48-22.64-27.33-36.81-14.021.92-25.61-22.38-22.01-8.68-32.43-11.50
Valuation
Enterprise Value -4.80M-5.28M-4.09M-5.51M-6.96M162.18M171.98M167.11M218.16M161.38M287.55M123.00M219.22M139.97M-9.75M5.80M14.93M-4.50M523.35M
Market Capitalization 238.28M246.82M203.05M235.95M185.99M311.04M163.82M250.22M158.86M15.83M12.74M29.16M23.25M543.55M
Return Ratios
Return on Sales 16.74%16.35%22.05%33.08%67.89%-2.23%-2.71%-2.95%-3.00%76.58%
Return on Capital Employed -1.74%-0.59%-0.39%-0.47%-0.61%-0.70%-0.50%-0.57%-0.60%-0.71%-1.93%-1.65%-105.20%
Return on Assets -1.00%-0.49%-0.34%-0.40%-0.50%-0.60%-0.45%-0.51%-0.54%-0.60%-0.93%-1.62%-4.25%
Return on Equity 0.27%1.61%-0.43%-0.52%-0.65%-0.94%-0.86%-0.93%-1.03%-1.33%-2.58%-8.45%41.55%